94-24250. Notice of Opportunity to Initiate Negotiations for TSCA Section 4 Enforceable Consent Agreements; Solicitation of Testing Proposals for ATSDR Chemicals  

  • [Federal Register Volume 59, Number 189 (Friday, September 30, 1994)]
    [Unknown Section]
    [Page 0]
    From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
    [FR Doc No: 94-24250]
    
    
    [[Page Unknown]]
    
    [Federal Register: September 30, 1994]
    
    
    -----------------------------------------------------------------------
    
    ENVIRONMENTAL PROTECTION AGENCY
    [OPPTS-42052P; FRL-4756-5]
    
     
    
    Notice of Opportunity to Initiate Negotiations for TSCA Section 4 
    Enforceable Consent Agreements; Solicitation of Testing Proposals for 
    ATSDR Chemicals
    
    AGENCY: Environmental Protection Agency (EPA).
    
    ACTION: Notice.
    
    -----------------------------------------------------------------------
    
    SUMMARY: This notice invites manufacturers and processors of certain 
    chemical substances who wish to participate in testing negotiations for 
    various chemicals to develop and submit testing program proposals to 
    EPA. The chemicals are hazardous substances identified for data needs 
    by the Agency for Toxic Substances and Disease Registry (ATSDR), 
    National Toxicological Program (NTP) and EPA pursuant to section 
    104(i)(5) of the Comprehensive Environmental Response, Compensation and 
    Liability Act of 1980 (CERCLA or Superfund)(42 U.S.C. 9601-9675). These 
    12 chemical substances are vinyl chloride, benzene, trichloroethylene, 
    tetrachloroethylene, hydrogen cyanide, sodium cyanide, toluene, 
    methylene chloride, chloroethane, mercury, chromium, and beryllium. 
    These substances and associated data needs appear in Table 1 below. The 
    specific forms of the metals mercury, chromium, and beryllium to be 
    tested are yet to be determined; EPA will solicit testing proposals for 
    the specific forms of these metals at a later date. Testing proposals 
    should cover all identified data needs of a substance (or multiple 
    substances) in order to be considered for Enforceable Consent Agreement 
    (ECA) negotiation. If, after receiving testing proposals, EPA elects to 
    pursue negotiations for one or more ECAs applicable to specific 
    chemicals, EPA will solicit requests to be designated an interested 
    party at that point. EPA has authority to require testing for these 12 
    chemical substances under section 4 of the Toxic Substances Control Act 
    (TSCA)(15 U.S.C. 2601-2692) and if an ECA-based approach does not prove 
    viable, EPA would proceed with rulemaking to require the needed 
    testing.
    
    DATES: Written testing proposals must be received by November 29, 1994. 
    EPA may extend the deadline for receipt of testing proposals upon a 
    showing of good faith efforts to develop testing proposals by the 
    initial deadline.
    
    ADDRESSEES: Submit three copies of written testing proposals to TSCA 
    Docket Receipts (7407), Office of Pollution Prevention and Toxics, 
    Environmental Protection Agency, Rm. NE B607, 401 M St., SW., 
    Washington, DC 20460. Submissions should bear the document control 
    number (OPPTS-42052P; FRL-4756-5). The public record supporting this 
    action, including comments, is available for public inspection at the 
    above address from 12 noon to 4 p.m., Monday through Friday, except 
    legal holidays.
    
    FOR FURTHER INFORMATION CONTACT: Susan B. Hazen, Director, 
    Environmental Assistance Division (7408), Rm. E-543B, 401 M St., SW., 
    Washington, DC 20460, (202) 554-1404, TDD (202) 554-0551. For specific 
    information regarding this action or related activities, contact Brian 
    P. Riedel, Project Manager, Chemical Testing and Information Branch 
    (7405), Rm. NE-1606, 401 M St., SW., Washington, DC 20460, (202) 260-
    0321.
    
    SUPPLEMENTARY INFORMATION:
    
    I. Background
    
     A. Solicitation for Testing Proposals
    
         EPA's procedures for requiring the testing of chemical substances 
    under section 4 of TSCA include the adoption of ECAs and the 
    promulgation of test rules. On numerous occasions, chemical companies 
    have approached EPA to negotiate ECAs for testing chemicals which are 
    likely to become the subject of proposed test rules. EPA will follow 
    the procedures outlined in unit II of this notice to develop ECAs.
    
    B. Chemical Data Needs
    
         The data needs which are the subject of this notice were 
    determined in accordance with the requirements of the Superfund 
    Amendments and Reauthorization Act (SARA) of 1986 which amended and 
    extended CERCLA.
         Section 104(i) of CERCLA requires ATSDR and EPA to prepare and 
    revise a list of hazardous substances which are most commonly found at 
    facilities on the CERCLA National Priorities List (NPL) and which ATSDR 
    and EPA, in their sole discretion, determine are posing the most 
    significant potential threat to human health. The lists of these 275 
    hazardous substances were published in the Federal Register on April 
    17, 1987 (52 FR 12866); October 20, 1988 (53 FR 41280); October 26, 
    1989 (54 FR 43615); October 17, 1990 (55 FR 42067); October 17, 1991 
    (55 FR 52166); October 28, 1992 (57 FR 48801); and October 18, 1993 (58 
    FR 53739).
         Section 104(i) of CERCLA also directs ATSDR to prepare 
    toxicological profiles of each listed hazardous substance. Section 
    104(i)(3) outlines the content of these profiles. Each profile is 
    required to include an examination, summary and interpretation of 
    available toxicological information and epidemiologic evaluations in 
    order to ascertain the levels of significant human exposure for the 
    substance and the associated health effects. The profiles must also 
    include a determination of whether adequate information on the health 
    effects of each substance is available or in the process of 
    development. ATSDR has prepared 110 toxicological profiles covering 195 
    substances. (One toxicological profile may cover several related 
    substances).
         Under CERCLA, section 104(i)(5), when adequate information is not 
    available on the health effects of each substance, ATSDR, in 
    cooperation with the National Toxicology Program (NTP), is required to 
    assure the initiation of a research program designed to determine such 
    health effects (and techniques for developing methods to determine such 
    health effects).
        As the first step in developing its health effects research 
    program, ATSDR identified data needs for each substance in the 
    toxicological profiles. These data needs were reviewed by scientists 
    from ATSDR, NTP, EPA and the Centers for Disease Control, peer reviewed 
    by an external review panel, and made available for public comment. 
    Prior to final publication of the toxicological profiles, ATSDR 
    considered all public comments it received regarding identification of 
    data needs for the substances.
         The next step in the development of the health effects research 
    program (or the substance-specific research program) involved the 
    creation of the ``Decision Guide for Identifying Substance-Specific 
    Data Needs Related to Toxicological Profiles'' (Decision Guide), 
    published in the Federal Register on September 11, 1989 (54 FR 37618). 
    Applying the principles discussed in the Decision Guide, ATSDR 
    published the ``Identification of Priority Data Needs for 38 Priority 
    Hazardous Substances'' in the Federal Register on October 17, 1991 (56 
    FR 52178). As required by CERCLA, section 104(i)(5), ATSDR considered 
    recommendations from the Interagency Testing Committee (ITC), and, with 
    EPA, coordinated development of these priority data needs with NTP and 
    with programs of toxicological testing established under TSCA and the 
    Federal Insecticide, Fungicide and Rodenticide Act (FIFRA)(7 U.S.C. 
    136). The purpose of such coordination is to avoid duplication of 
    effort and to assure that the listed hazardous substances are tested 
    thoroughly at the earliest practicable date. ATSDR also considered 
    public comments on identification of the priority data needs. On 
    November 16, 1992, ATSDR published the ``Announcement of Final Priority 
    Data Needs for 38 Priority Hazardous Substances'' in the Federal 
    Register (57 FR 54150). Copies of the FR actions cited above are 
    available in the docket established for this action (OPPTS-42052P; FRL-
    4756-5).
        CERCLA, section 104(i)(5)(C) provides that TSCA authorities may be 
    used to carry out the health effects research program. CERCLA, section 
    104(i)(5)(D) declares that:
    
        [i]t is the sense of the Congress that the costs of [conducting 
    health effects research programs] be borne by the manufacturers and 
    processors of the hazardous substances in question, as required in 
    programs of toxicological testing under the Toxic Substances Control 
    Act.
    
    
         In October 1992, ATSDR requested that EPA test 38 substances using 
    authorities under TSCA and FIFRA. EPA coordinated extensively with 
    other Federal agencies (including the Occupational Safety and Health 
    Administration, National Institute for Occupational Safety and Health, 
    Mine Safety and Health Administration, and the Consumer Product Safety 
    Commission) and among its own programs (including Office of Air and 
    Radiation, Office of Water, Office of Solid Waste and Emergency 
    Response, and Office of Research and Development) to evaluate ATSDR's 
    request for testing. In addition, EPA, ATSDR, and the National 
    Institute of Environmental Health Sciences (NIEHS) met as members of 
    the Tri-Agency Superfund Applied Research Committee (TASARC) to discuss 
    ATSDR's data needs and EPA's response. Copies of the minutes of the 
    TASARC meetings are available in the docket established for this 
    action.
        In response to ATSDR's initial request to test 38 substances, EPA 
    deleted substances from the initial list and deleted and added 
    associated data needs based on various factors including, but not 
    limited to, the appropriateness of using TSCA authority to require 
    testing of certain substances and the needs of other Federal Agencies 
    and EPA programs for certain test data. Relevant correspondence between 
    EPA and ATSDR regarding these selections is available in the docket 
    established for this action. In a letter dated November 9, 1993, EPA 
    informed ATSDR that EPA would pursue testing of ATSDR substances under 
    section 4 of TSCA. The ATSDR list of 38 substances was modified to 
    contain the 12 substances shown in Table 1 below with a summary 
    description of data needs. These substances will be added to the next 
    edition of the Office of Pollution Prevention and Toxics' Master 
    Testing List scheduled for release in FY '95. Further description of 
    the data needs are available in the docket established for this action.
        Note that TASARC has set up a workgroup to identify the specific 
    forms of the metals mercury, chromium and beryllium to be tested. This 
    workgroup will consider the needs of other Federal Agencies and EPA 
    programs. In addition, EPA will solicit testing proposals for the 
    specific forms of these metals at a later date. Note also that EPA has 
    not yet developed testing guidelines for certain endpoints indicated in 
    Table 1 below. EPA particularly encourages submission of testing 
    guidelines for these endpoints which may be used as part of a testing 
    proposal.
        EPA realizes that under certain circumstances, as outlined below, 
    route-to-route extrapolation based on valid pharmacokinetic (PK) data 
    can offer a useful and less expensive alternative to retesting by 
    another route of exposure to chemical substances that have already been 
    tested by one route. Therefore, EPA will consider entering into ECAs 
    for PK testing under protocols proposed by prospective test sponsors.
        EPA will consider route-to-route extrapolation of toxicity data 
    from routes other than those proposed in Table 1 below when it is 
    scientifically reasonable to empirically derive the risk. Derivation of 
    the risk is only reasonable when portal-of-entry effects and first-pass 
    effects can be ruled out or adequately characterized. Regardless of the 
    toxic endpoint considered, EPA's ability to perform quantitative route-
    to-route extrapolation is critically dependent on the amount and type 
    of data available. The minimum information needed includes both the 
    nature of the toxic effects and a description of the relationship 
    between exposure and the toxic effect.
        The preferred method for performing route-to-route extrapolation 
    involves the development of a physiologically-based pharmacokinetic 
    (PBPK) model that describes the disposition (deposition, absorption, 
    distribution, metabolism, and elimination) of the chemical for the 
    routes of interest. PBPK models must be used in conjunction with 
    toxicity and mechanistic studies in order to relate the effective dose 
    associated with an effect for the test species and conditions to other 
    scenerios.
         The primary purpose of this ASTDR/EPA health effects testing 
    program is to meet the substance-specific information needs of the 
    public and the scientific community, and, consistent with the 
    guidelines discussed in the Decision Guide, this testing program will 
    supply toxicity and exposure information which will assist in the 
    development of Superfund health assessments by ASTDR. In addition, 
    because of the involvement by other Federal Agencies and EPA offices in 
    reviewing the testing needs identified for these chemicals, this 
    testing program will supply test data which will also meet the needs of 
    other Federal Agencies and EPA programs. 
    
                  Table 1.--Data Needs and Testing Guidelines               
    ------------------------------------------------------------------------
     Chemical and CAS No.       Proposed Testing         Guideline (40 CFR) 
    ------------------------------------------------------------------------
    Vinyl chloride (75-01- Reproductive inhalation...  R                    
     4).                                                                    
                                                                            
                           Developmental inhalation..  D                    
                                                                            
                           Neurotoxicity inhalation..  N                    
                                                                            
    Benzene (71-43-2)....  Subchronic oral...........  798.2650             
                                                                            
                           Subchronic inhalation.....  798.2450             
                                                                            
                           Neurotoxicity inhalation..  N                    
                                                                            
                           Functional observational                         
                            battery                                         
                                                                            
                           Motor activity                                   
                                                                            
                           Neuropathology              .....................
                                                                            
                           Reproductive inhalation...  R                    
                                                                            
    Trichloroethylene (79- Acute oral................  798.1175             
     01-6).                                                                 
                                                                            
                           Subchronic oral...........  798.2650             
                                                                            
                           Immunotoxicity oral.......  I                    
                                                                            
    Tetrachloroethylene    Acute inhalation..........  A                    
     (127-18-4).                                                            
                                                                            
                           Reproductive inhalation...  R                    
                                                                            
                           Neurotoxicity subchronic    N                    
                            inhalation.                                     
                                                                            
                           Functional observational                         
                            battery                                         
                                                                            
                           Motor activity                                   
                                                                            
                           Neuropathology                                   
                                                                            
                           Developmental inhalation..  D                    
                                                                            
                           Immunotoxicity inhalation.  I                    
                                                                            
    Hydrogen cyanide (74-  Acute inhalation..........  A                    
     90-8).                                                                 
                                                                            
                           Subchronic inhalation.....  798.2450             
                                                                            
                           Developmental inhalation..  D                    
                                                                            
                           Neurotoxicity subchronic    N                    
                            inhalation.                                     
                                                                            
                           Functional observational                         
                            battery                                         
                                                                            
                           Motor activity                                   
                                                                            
                           Neuropathology                                   
                                                                            
    Sodium cyanide (143-   Developmental oral........  D                    
     33-9).                                                                 
                                                                            
    Toluene (108-88-3)...  Comparative                 PK                   
                            pharmacokinetic.                                
                                                                            
                           Immunotoxicity oral.......  I                    
                                                                            
    Methylene chloride     Subchronic oral...........  798.2650             
     (75-09-2).                                                             
                                                                            
                           Developmental oral........  D                    
                                                                            
                           Neurotoxicity subchronic    N                    
                            oral.                                           
                                                                            
                           Functional observational                         
                            battery                                         
                                                                            
                           Motor activity                                   
                                                                            
                           Neuropathology                                   
                                                                            
                           Immunotoxicity oral.......  I                    
                                                                            
    Chloroethane* (Ethyl   Comparative                 PK                   
     chloride) (75-00-3).   pharmacokinetic.                                
                                                                            
    Mercury**(TBD).......  ..........................  .....................
                                                                            
    Chromium**(TBD)......  ..........................  .....................
                                                                            
    Beryllium**(TBD).....  ..........................  .....................
    ------------------------------------------------------------------------
    
    
    Notes:
        *Note that a soon-to-be-published proposed test rule on 
    hazardous air pollutants (HAPs) will cover chloroethane.
        **A workgroup set up by TASARC is in the process of identifying 
    the specific forms of these metals.
        TBD -- The Chemical Abstract Service Registry Number(s) for the 
    chemical(s) to be tested is yet to be determined.
        R -- Proposed revised EPA guidelines for reproductive toxicity 
    testing are under development and are anticipated to be finalized in 
    the near future. Copies of the latest draft to date are available in 
    the docket established for this action.
        D -- Proposed revised EPA guidelines for developmental toxicity 
    testing are under development and are anticipated to be finalized in 
    the near future. Copies of the latest draft to date are available in 
    the docket established for this action.
        N -- EPA intends for parties subject to neurotoxicity testing 
    requirements under this rule to follow the 1991 Neurotoxicology 
    Testing Guidelines which are available in the docket established for 
    this action.
        I -- A workgroup established by the Tri-Agency Superfund Applied 
    Research Committee (TASARC) is developing immunotoxicity testing 
    guidelines.
         A -- Revised EPA guidelines for acute inhalation testing are 
    under development and will soon be published with a proposed test 
    rule on HAPs. Copies of the latest draft to date are available in 
    the docket established for this action.
         PK -- EPA has developed testing guidelines which may be used 
    for conducting comparative pharmokinetic testing. These final 
    guidelines are awaiting publication and are available in the docket 
    established for this action.
    
    II. Procedures for Development of ECAs
    
         EPA will follow the procedures outlined below to develop ECAs for 
    the chemical substances listed in Table 1 above.
         1. Submission of testing proposals for ECA negotiations. Following 
    publication of this Notice, manufacturers and processors have 60 days 
    to develop testing proposals for the chemical substances listed in 
    Table 1 above that they wish EPA to consider as candidates for ECA 
    negotiations. EPA may extend the deadline for receipt of testing 
    proposals upon a showing of good faith efforts to develop testing 
    proposals by the initial deadline. The testing proposals should 
    describe the testing to be performed in detail (test guideline or 
    protocol, including route of administration, species, etc.) and explain 
    in detail where there are deviations from tests proposed by EPA in 
    Table 1 above. The Agency suggests as a model the testing proposal 
    submitted on N-methylpyrrolidone (NMP) by the NMP Producers Group on 
    September 11, 1992 found in the docket established for this action. In 
    order for a testing proposal to be eligible for consideration, the 
    proposal should cover all identified data needs of a substance (or 
    multiple substances).
         2. Agency selection of most likely candidates for the ECA program. 
     EPA will review the submissions and select the most promising 
    submissions as candidates for negotiation. Submissions which fully 
    address EPA's concerns will have a higher chance of success than those 
    which do not fully address all data needs issues.
         3. Formal solicitation of ``interested parties'' in the Federal 
    Register. If EPA selects a proposal as a candidate for negotiations, 
    such negotiations will be conducted pursuant to procedures described in 
    40 CFR 790.28. Accordingly, EPA will publish a notice in the Federal 
    Register soliciting persons interested in participating in or 
    monitoring negotiations for the development of an ECA, to so notify the 
    Agency in writing. Those individuals and groups who respond to EPA's 
    notice by the deadline established in the notice will have the status 
    of ``interested parties'' and will be afforded opportunities to 
    participate in the negotiation process. Designation as an ``interested 
    party'' will not incur any obligations. Submitters of testing proposals 
    will be considered interested parties with regard to the subject(s) of 
    their proposals and need not respond to the solicitation notice.
         4. Negotiation of testing program and development of an ECA. 
    Negotiations will be conducted in meetings open to the public. 
    Notification of meetings will be given only to persons identified as 
    interested parties. The first negotiation meeting will establish the 
    period for negotiation. If agreement is not reached within this 
    prescribed time limit and EPA chooses not to extend the negotiation 
    period, negotiations will be terminated and testing will be required 
    under a rule.
         5. Approval of the ECA by interested parties and EPA and 
    publication of a notice in the Federal Register. After EPA and 
    interested parties have agreed in principle on the terms of the ECA, 
    the ECA text will be sent for approval to interested parties who are 
    actual participants in the negotiation. Subsequent to approval of the 
    ECA, EPA will publish a notice in the Federal Register summarizing the 
    testing program and announcing that in lieu of a test rule, the Agency 
    has issued a testing Consent Order that incorporates the ECA.
    
    III. Public Record
    
         EPA has established a record for this action (docket control 
    number OPPTS-42052P; FRL-4756-5). The record includes basic information 
    considered by EPA in developing this action. EPA will supplement the 
    record with additional information as it is received.
         A public version of this record is available in the TSCA 
    Nonconfidential Information Center (NCIC) from 12 noon to 4 p.m., 
    Monday through Friday, except legal holidays. The NCIC is located in 
    Rm. NE-B607, Mail Code 7407, 401 M St., SW., Washington, DC, 20460. 
    Written requests for copies of documents contained in this record may 
    be sent to the above address or faxed to (202) 260-9555.
        Authority: 15 U.S.C. 2603.
    
        Dated: September 21, 1994.
    
    Charles M. Auer,
    Director, Chemical Control Division, Office of Pollution Prevention and 
    Toxics.
    [FR Doc. 94-24250 Filed 9-29-94; 8:45 am]
    BILLING CODE 6560-50-P
    
    
    

Document Information

Published:
09/30/1994
Department:
Environmental Protection Agency
Entry Type:
Uncategorized Document
Action:
Notice.
Document Number:
94-24250
Dates:
Written testing proposals must be received by November 29, 1994. EPA may extend the deadline for receipt of testing proposals upon a showing of good faith efforts to develop testing proposals by the initial deadline.
Pages:
0-0 (1 pages)
Docket Numbers:
Federal Register: September 30, 1994, OPPTS-42052P, FRL-4756-5